And high levels of IL-7 are associated with autoimmune diseases such as rheumatoid arthritis [25], whether boosting IL-7 would have similar side effects as inhibiting TGF-β or more is not known, which may limit the application of IL-7 boosting strategy to IPF patients. Here, TGFB1 is linked to idiopathic pulmonary fibrosis.